FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer

Abstract

International audience

Keywords

FOLFIRINOXGemcitabineIrinotecanOxaliplatinMedicineOncologyRegimenPancreatic cancerInternal medicineChemotherapyFluorouracilCancerColorectal cancer

Affiliated Institutions

Related Publications

A systematic review of the clinical effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer

Gerlinde Pilkington , Angela Boland , Tamara Brown +3 more

Our aim was to evaluate the clinical effectiveness of chemotherapy treatments currently licensed in Europe and recommended by the National Institute for Health and Care Excellen...

2015 Thorax 116 citations

Bayesian network meta-comparison of maintenance treatments for stage IIIb/IV non-small-cell lung cancer (NSCLC) patients with good performance status not progressing after first-line induction chemotherapy: Results by performance status, EGFR mutation, histology and response to previous induction

Pui San Tan , Gilberto Lopes , Sanchalika Acharyya +2 more

Maintenance treatments show clinically meaningful survival benefits in good performance status patients with advanced NSCLC not progressing after first-line chemotherapy. Benefi...

2015 European Journal of Cancer 17 citations

Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer

Enriqueta Felip , Flávia De Angelis , Manuel Dómine +26 more

In patients with previously untreated metastatic nonsquamous NSCLC without EGFR or ALK mutations, the addition of pembrolizumab to standard chemotherapy of pemetrexed and a plat...

2018 New England Journal of Medicine 6245 citations

Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC

Mark A. Socinski , Robert M. Jotte , Federico Cappuzzo +17 more

The addition of atezolizumab to bevacizumab plus chemotherapy significantly improved progression-free survival and overall survival among patients with metastatic nonsquamous NS...

2018 New England Journal of Medicine 3592 citations

Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer

Luis Paz‐Ares , Alexander Luft , David Vicente +20 more

In patients with previously untreated metastatic, squamous NSCLC, the addition of pembrolizumab to chemotherapy with carboplatin plus paclitaxel or nab-paclitaxel resulted in si...

2018 New England Journal of Medicine 3472 citations

Publication Info

Year: 2011
Type: article
Volume: 364
Issue: 19
Pages: 1817-1825
Citations: 7440
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

7440

OpenAlex

Cite This

APA Style

                            
                                
                                    Thierry Conroy, 
                                
                                    Françoise Desseigne, 
                                
                                    Marc Ychou
                                
                                et al.
                            
                            (2011). 
                            FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer. 
                            New England Journal of Medicine
                            , 364
                            (19)
                            , 1817-1825.
                            https://doi.org/10.1056/nejmoa1011923
                        

Identifiers

DOI: 10.1056/nejmoa1011923